KIAA0232

Across TCGA pan-cancer cohorts, KIAA0232 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of KIAA0232’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where KIAA0232 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KIAA0232 is over-expressed in tumor, although a few such as COAD and BLCA show the opposite, repressed pattern.

LIHC, COAD, and BLCA are the cancer types where KIAA0232 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KIAA0232 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	II,III,IV	+1.285	<.001	9	view →
COAD	Female	All	−0.838	<.001	9	view →
BLCA	Male	IV	−0.867	<.001	8	view →
THCA	Male	III,IV	−0.814	<.001	8	view →
HNSC	Male	All	−0.588	<.001	8	view →
KIRC	Male	II,III,IV	−0.566	<.001	6	view →
CHOL	All	All	+1.463	<.001	5	view →
LUSC	Male	All	−0.541	<.001	5	view →
LUAD	Female	II,III,IV	−0.472	.007	5	view →
BRCA	Female	All	−0.233	.008	4	view →
READ	Female	All	−0.825	.001	2	view →
UCEC	All	All	−0.783	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

KIAA0232–LIHC

Open the LIHC breakdown →